Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human CD45 ELISA Kit (AC3142)
Cat.#: ASET-1731
Specifications
Description Human CD45 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CD45 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.09 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2.5-40 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2131 Rat Pofut1 ELISA Kit (AC3542) Quantitative inquiry ASET-1729 Rabbit FGF2 ELISA Kit (AC3140) Quantitative inquiry ASET-1129 Rat CNTF ELISA Kit (AC2540) Quantitative inquiry ASET-2139 Rat Neurotensin ELISA Kit (AC3550) Quantitative inquiry ASET-1099 Human FTO ELISA Kit (AC2510) Quantitative inquiry ASET-1877 Mouse CacyBP ELISA Kit (AC3288) Quantitative inquiry ASET-1292 Human Glucose 6 Phosphate Isomerase ELISA Kit (AC2703) Quantitative inquiry ASET-1545 Mouse Dystrophin ELISA Kit (AC2956) Quantitative inquiry ASET-2381 Human Antidiuretic Hormone ELISA Kit (AC3792) Quantitative inquiry ASET-1931 Rat Aromatase ELISA Kit (AC3342) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket